Literature DB >> 8485615

Regulation of neural responses in the canine pyloric sphincter by opioids.

O Bayguinov1, K M Sanders.   

Abstract

1. Regulation of excitatory and inhibitory junction potentials (e.j.ps and i.j.ps) by opioid peptides was studied in isolated muscle strips from the pyloric sphincter of the dog. 2. Methionine enkephalin (MetEnk; 10(-10) to 10(-6) M) and [D-Ala2, D-Leu5] enkephalin (DADLE; 10(-11) to 10(-7) M), a delta-specific opioid agonist, inhibited i.j.ps and e.j.ps recorded from cells in the myenteric and submucosal regions of the circular muscle layer. These compounds had no effect on resting potential or slow wave activity suggesting that the effects on junction potentials were not due to direct effects on smooth muscle cells. 3. MetEnk and DADLE caused similar effects on junction potentials in preparations in which the myenteric plexus was removed, suggesting that opioids inhibit pre-junctional effects on nerve fibres within the muscularis externa. 4. Inhibition of junction potentials by MetEnk and DADLE was blocked by approximately the same extent by naloxone (10(-6) M) and ICI 174,864 (10(-6) M), a delta-specific antagonist. 5. MetEnk and DADLE blocked a portion of the i.j.p. that was sensitive to arginine analogues; after treatment with N omega-nitro-L-arginine methyl ester (L-NAME, 10(-4) M), MetEnk and DADLE had no further effect on i.j.ps. These data suggest that opioids regulate nitric oxide-dependent neurotransmission. 6. Naloxone (10(-6) M) alone had no effect on i.j.ps elicited by short trains of electrical field stimuli. 7. I.j.p. amplitude was reduced after a period of conditioning stimulation (2 min, 30 Hz, 30 V). Naloxone blocked the post-stimulation inhibition. Repetitive stimulation at high frequencies (30 Hz) resulted in sustained hyperpolarization. Naloxone increased the amplitude of the hyperpolarization responses elicited by high frequency stimulation.8. These results show that e.j.ps and i.j.ps in the canine pylorus are inhibited by opioids. A portion of the inhibitory effects appears to be mediated via delta receptors.9. Although pyloric muscles are richly innervated by nerves containing opioid peptides, brief trains of stimuli do not appear to release concentrations of opioids that are effective in regulating junction potentials. Higher frequency stimulation (or longer durations of stimulation) appear to be necessary to release concentrations of opioids that are effective in modulating the amplitude of junction potentials.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8485615      PMCID: PMC1908132          DOI: 10.1111/j.1476-5381.1993.tb13500.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Endogenous opiate receptor ligand: electrically induced release in the guinea pig ileum.

Authors:  M M Puig; P Gascon; G L Craviso; J M Musacchio
Journal:  Science       Date:  1977-01-28       Impact factor: 47.728

2.  Factors influencing the release of acetylcholine from the myenteric plexus of the ileum of the guinea-pig and rabbit.

Authors:  A L Cowie; H W Kosterlitz; A A Waterfield
Journal:  Br J Pharmacol       Date:  1978-12       Impact factor: 8.739

3.  Distribution of peptide- and catecholamine-containing neurons in the gastro-intestinal tract of rat and guinea-pig: immunohistochemical studies with antisera to substance P, vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin and dopamine beta-hydroxylase.

Authors:  M Schultzberg; T Hökfelt; G Nilsson; L Terenius; J F Rehfeld; M Brown; R Elde; M Goldstein; S Said
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

Review 4.  Neuronal peptides in the intestine: distribution and possible functions.

Authors:  J B Furness; M Costa; R Franco; I J Llewellyn-Smith
Journal:  Adv Biochem Psychopharmacol       Date:  1980

5.  Inhibition of gastric emptying by enkephalin analogue.

Authors:  S N Sullivan; L Lamki; P Corcoran
Journal:  Lancet       Date:  1981-07-11       Impact factor: 79.321

6.  Distribution of opioid receptors in canine small intestine: implications for function.

Authors:  H D Allescher; S Ahmad; P Kostka; C Y Kwan; E E Daniel
Journal:  Am J Physiol       Date:  1989-06

7.  Action of morphine on the neuro-effector transmission in the guinea-pig ileum and in the mouse vas deferens.

Authors:  Y Ito; K Tajima
Journal:  J Physiol       Date:  1980-10       Impact factor: 5.182

8.  Evidence for vagal enkephalinergic neural control of the feline pylorus and stomach.

Authors:  R Edin; J Lundberg; L Terenius; A Dahlström; T Hökfelt; J Kewenter; H Ahlman
Journal:  Gastroenterology       Date:  1980-03       Impact factor: 22.682

9.  Effect of naloxone and morphine on gastric acid secretion and on serum gastrin and pancreatic polypeptide concentrations in humans.

Authors:  M Feldman; J H Walsh; I L Taylor
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

10.  Release-modulating acetylcholine receptors in cholinergic neurones of the guinea-pig ileum.

Authors:  P Fosbraey; E S Johnson
Journal:  Br J Pharmacol       Date:  1980-02       Impact factor: 8.739

View more
  4 in total

1.  Localization and regulation of fluorescently labeled delta opioid receptor, expressed in enteric neurons of mice.

Authors:  Daniel P Poole; Juan-Carlos Pelayo; Gregory Scherrer; Christopher J Evans; Brigitte L Kieffer; Nigel W Bunnett
Journal:  Gastroenterology       Date:  2011-05-27       Impact factor: 22.682

Review 2.  Gastroparesis.

Authors:  Michael Camilleri; Kenton M Sanders
Journal:  Gastroenterology       Date:  2021-10-27       Impact factor: 22.682

3.  Relationship of motor mechanisms to gastroparesis symptoms: toward individualized treatment.

Authors:  Michael Camilleri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-02-10       Impact factor: 4.052

Review 4.  Endogenous opiates: 1993.

Authors:  G A Olson; R D Olson; A J Kastin
Journal:  Peptides       Date:  1994       Impact factor: 3.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.